Citation Impact
Citing Papers
TRP Channels as Potential Drug Targets
2017
The type III TGF-β receptor regulates epithelial and cancer cell migration through β-arrestin2-mediated activation of Cdc42
2009
Effect of Low-Fat Diets on Plasma Levels of NF-κB–Regulated Inflammatory Cytokines and Angiogenic Factors in Men with Prostate Cancer
2011
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Attenuated Transforming Growth Factor β Signaling Promotes Nuclear Factor-κB Activation in Head and Neck Cancer
2009
Novel Role of Thromboxane Receptors β Isoform in Bladder Cancer Pathogenesis
2008
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
2020 StandoutScience
Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy
2011
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants
2021
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
2020 Standout
TGF-β – an excellent servant but a bad master
2012
The emerging role of ACE2 in physiology and disease
2007
A Single Low-Fixed Dose of Rituximab to Salvage Renal Transplants From Refractory Antibody-Mediated Rejection
2009
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
Transforming growth factor-β and the hallmarks of cancer
2010
Intravenous Immunoglobulin Induction Treatment in Flow Cytometry Cross-Match—Positive Kidney Transplant Recipients
2005
Ketone bodies as signaling metabolites
2013
Disseminated Intravascular Coagulation (DIC) in a Kidney Donor Associated with Transient Recipient DIC
2005
Obesity and Prostate Cancer: Weighing the Evidence
2012
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
2015 Standout
The type III transforming growth factor- receptor negatively regulates nuclear factor kappa B signaling through its interaction with -arrestin2
2009
Fish oil slows prostate cancer xenograft growth relative to other dietary fats and is associated with decreased mitochondrial and insulin pathway gene expression
2013
TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling
2013
Bone marrow NG2+/Nestin+ mesenchymal stem cells drive DTC dormancy via TGF-β2
2021
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Comparison of Combination Plasmapheresis/IVIg/ Anti-CD20 Versus High-Dose IVIg in the Treatment of Antibody-Mediated Rejection
2009
Determinants of Poor Graft Outcome in Patients with Antibody-Mediated Acute Rejection
2007
Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial
2010 StandoutNobel
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
2010 Standout
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
β-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expression
2011
Posttransplant Prophylactic Intravenous Immunoglobulin in Kidney Transplant Patients at High Immunological Risk: A Pilot Study
2007
A compendium of proteins that interact with HIF-1α
2017 StandoutNobel
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
2013 Standout
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
Epidemiology of Prostate Cancer
2019 Standout
Insulin receptor expression by human prostate cancers
2008
Cancer stem cells revisited
2017 Standout
WNT–β-catenin signalling — a versatile player in kidney injury and repair
2020
Engineering the perfect (bacterial) cancer therapy
2010 Standout
Diet and prostate cancer: mechanisms of action and implications for chemoprevention
2010
Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes
2007
Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?
2010
The molecular biology of head and neck cancer
2010 Standout
Role of transforming growth factor-β superfamily signaling pathways in human disease
2008
Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals
2023 StandoutNobel
Organization and Evolution of Brain Lipidome Revealed by Large-Scale Analysis of Human, Chimpanzee, Macaque, and Mouse Tissues
2015 StandoutNobel
The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis
2011
Chronic kidney disease
2011 Standout
Therapeutic Apheresis for Renal Disorders
2012
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Chemistry and biology of reactive oxygen species in signaling or stress responses
2011 Standout
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Frequency and Clinical Implications of Development of Donor-Specific and Non–Donor-Specific HLA Antibodies after Kidney Transplantation
2005
Extracellular matrix structure
2015 Standout
Summary of FDA Antibody-Mediated Rejection Workshop
2011
Plasmapheresis Therapy in Renal Transplant Patients: Five-Year Experience
2011
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
2012 Standout
A Cell-Penetrating Scorpion Toxin Enables Mode-Specific Modulation of TRPA1 and Pain
2019 StandoutNobel
Regulation of intestinal epithelial permeability by tight junctions
2012 Standout
Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment
2013
The emerging role of TGF-β superfamily coreceptors in cancer
2009
Chronic kidney disease: global dimension and perspectives
2013 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Burden of Chronic Kidney Disease: An International Perspective
2010
Recent developments in HIV and the kidney
2008
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
TGF-β and fibrosis in different organs — molecular pathway imprints
2009 Standout
Eicosanoids and cancer
2010 Standout
Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment
2008
Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2
2008
TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease
2016 Standout
Prevention and treatment of alloantibody-mediated kidney transplant rejection
2011
Amino Acid Transport Across Mammalian Intestinal and Renal Epithelia
2008
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
2020 Standout
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease
2015 Standout
Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes
2011 Standout
Tissue-Specific Amino Acid Transporter Partners ACE2 and Collectrin Differentially Interact With Hartnup Mutations
2008
The type III TGF- receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation
2007
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Profiling protein thiol oxidation in tumor cells using sulfenic acid-specific antibodies
2009
A protein complex in the brush‐border membrane explains a Hartnup disorder allele
2008
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Thromboxane A2 Receptors in Prostate Carcinoma: Expression and Its Role in Regulating Cell Motility via Small GTPase Rho
2008
Search and sequence analysis tools services from EMBL-EBI in 2022
2022 Standout
Therapeutic plasma exchange for desensitization prior to transplantation in ABO‐incompatible renal allografts
2009
Angiotensin-Converting Enzyme 2: The First Decade
2011
Treatment of antibody‐mediated rejection in renal transplant patients: a clinical practice survey
2014
Diabetes and Cancer
2010 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Guidelines for the Management of Chronic Kidney Disease in HIV-Infected Patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America
2005
The Transforming Growth Factor-β Type III Receptor Mediates Distinct Subcellular Trafficking and Downstream Signaling of Activin-like Kinase (ALK)3 and ALK6 Receptors
2009
Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer
2014
Rituximab Therapy for Acute Humoral Rejection After Kidney Transplantation
2007
Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
2012 Standout
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Ectodomain shedding of TβRIII is required for TβRIII-mediated suppression of TGF-β signaling and breast cancer migration and invasion
2014
Endocytosis of the Type III Transforming Growth Factor-β (TGF-β) Receptor through the Clathrin-independent/Lipid Raft Pathway Regulates TGF-β Signaling and Receptor Down-regulation
2008
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Works of Timothy A. Fields being referenced
The Type III Transforming Growth Factor-β Receptor as a Novel Tumor Suppressor Gene in Prostate Cancer
2007
Loss of Betaglycan Expression in Ovarian Cancer: Role in Motility and Invasion
2007
TβRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity
2008
Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection1
2003
Aminoaciduria and altered renal expression of luminal amino acid transporters in mice lacking novel gene collectrin
2006
Prognostic significance of microvascular thrombosis in donor kidney allograft biopsies1
2003
Carbohydrate restriction, prostate cancer growth, and the insulin‐like growth factor axis
2007
The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection
2004
The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis
2006
Gq signaling causes glomerular injury by activating TRPC6
2015